Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy.

Abstract

A risk model for neutropenic complications was developed and validated in a large prospective cohort of patients who were beginning cancer chemotherapy that may guide the effective and cost-effective use of available supportive care.

Full Text

• DOI - Cancer (DOI)
• John Wiley & Sons, Inc. - full-text online
• Swets Information Services - full-text online
• OhioLINK Electronic Journal Center - full-text online
• EBSCO - full-text online

Subjects

• Aged
• Antineoplastic Agents
• Female
• Fever
• Humans
• Male
• Middle Aged
• Models, Biological
• Neoplasms
• Neutropenia
• Prognosis
• Prospective Studies
• Reproducibility of Results
• Risk Assessment

Similar articles

• Implementing an Evidence-Based Risk Assessment Tool to Predict Chemotherapy-Induced Neutropenia in Women With Breast Cancer. (2012-10-09)
• Management of chemotherapy-induced neutropenic fever. (2013-03-07)
• Canadian supportive care recommendations for the management of neutropenia in patients with cancer. (2008-03-04)
• The epidemiology and treatment of infections in cancer patients. (2008-02-18)
• Risk factors for febrile neutropenia during chemotherapy for HIV-related lymphoma. (2012-12-07)
• Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. (2012-11-29)
• Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department. (2013-01-09)
• Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older. (2013-04-19)
• Early discharge and ambulatory care of low-risk patients with neutropenic fever in Australia. (2012-05-21)

Authors

• Gary H Lyman
• Nicole M Kuderer
• Jeffrey Crawford
• Debra A Wolff
• Eva Culakova
• Marek S Poniewierski
• David C Dale

Publication date

2011-04-21

Journal

Journal topics

• Neoplasms

Language

Eng.

Copyright

Cancer

Department of Medicine, Duke University, Durham, North Carolina 27710, USA. Gary.Lyman [at] Duke.Edu

Release reference

Cancer. 2011 May;117(9):1917-27

Related books

• Books of Antineoplastic Agents
• Books of Fever
• Books of Models, Biological
• Books of Neoplasms
• Books of Neoplasms
• Books of Neutropenia
• Books of Prognosis
• Books of Prospective Studies
• Books of Reproducibility of Results
• Books of Risk Assessment